{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:35:21Z","timestamp":1794965721875,"version":"4.9.1"},"reference-count":27,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2023,2,15]]},"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>In ophthalmology, clinical trials (CTs) guide the treatment of diseases such as diabetic retinopathy, myopia, age-related macular degeneration, glaucoma and keratoconus with distinct presentations, pathological characteristics and responses to treatment in minority populations.<\/jats:p>\n                  <jats:p>Reporting gender and race and ethnicity in healthcare studies is currently recommended by National Institutes of Health (NIH) and Food and Drug Administration (FDA) guidelines to ensure representativeness and generalisability; however, CT results that include this information have been limited in the past 30 years.<\/jats:p>\n                  <jats:p>The objective of this review is to analyse the sociodemographic disparities in ophthalmological phases III and IV CT based on publicly available data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study included phases III and IV complete ophthalmological CT available from <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"clinicaltrials.org\">clinicaltrials.org<\/jats:ext-link>, and describes the country distribution, race and ethnicity description and gender, and funding characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>After a screening process, we included 654 CTs, with findings that corroborate the previous CT reviews\u2019 findings that most ophthalmological participants are white and from high-income countries. A description of race and ethnicity is reported in 37.1% of studies but less frequently included within the most studied ophthalmological specialty area (cornea, retina, glaucoma and cataracts). The incidence of race and ethnicity reporting has improved during the past 7\u2009years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Although NIH and FDA promote guidelines to improve generalisability in healthcare studies, the inclusion of race and ethnicity in publications and diverse participants in ophthalmological CT is still limited. Actions from the research community and related stakeholders are necessary to increase representativeness and guarantee generalisability in ophthalmological research results to optimise care and reduce related healthcare disparities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2022-001175","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:30:13Z","timestamp":1677144613000},"page":"e001175","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Sociodemographic disparities in ophthalmological clinical trials"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6847-6748","authenticated-orcid":false,"given":"Luis Filipe","family":"Nakayama","sequence":"first","affiliation":[{"name":"Laboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Greig","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Ophthalmology, The Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skyler","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Laboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Cornell University, Ithaca, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvina Pauline D.","family":"Santiago","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Philippine General Hospital, Manila, Metro Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warachaya","family":"Phanphruk","sequence":"additional","affiliation":[{"name":"Ophthalmology, Khon Kaen University, Nai Mueang, Khon Kaen, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khumbo","family":"Kalua","sequence":"additional","affiliation":[{"name":"Ophthalmology, Kamuzu University of Health Sciences, Blantyre, Southern Region, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo Anthony","family":"Celi","sequence":"additional","affiliation":[{"name":"Laboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA"},{"name":"Biostatistics, Harvard University T.H. Chan School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Vinicius Saito","family":"Regatieri","sequence":"additional","affiliation":[{"name":"Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"2025090109580751000_8.1.e001175.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030019","article-title":"Are racial and ethnic minorities less willing to participate in health research?","volume":"3","author":"Wendler","year":"2006","journal-title":"PLoS Med"},{"key":"2025090109580751000_8.1.e001175.2","unstructured":"NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. Available: https:\/\/grants.nih.gov\/policy\/inclusion\/women-and-minorities\/guidelines.htm [Accessed 20 Jun 2022]."},{"key":"2025090109580751000_8.1.e001175.3","unstructured":"Office of the Commissioner . FDA\u2019S action plan for FDASIA section 907: questions and answers. U.S. food and drug administration. Available: https:\/\/www.fda.gov\/regulatory-information\/food-and-drug-administration-safety-and-innovation-act-fdasia\/fdas-action-plan-fdasia-section-907-questions-and-answers"},{"key":"2025090109580751000_8.1.e001175.4","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.09.2475"},{"key":"2025090109580751000_8.1.e001175.5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/09286580802399102","article-title":"Measuring access to eye care: a public health perspective","volume":"15","author":"Zhang","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"2025090109580751000_8.1.e001175.6","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.8.1230"},{"key":"2025090109580751000_8.1.e001175.7","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.3.20"},{"key":"2025090109580751000_8.1.e001175.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.08.045"},{"issue":"Pt 4","key":"2025090109580751000_8.1.e001175.9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/eye.2000.154","article-title":"Does ethnic origin influence the incidence or severity of keratoconus?","volume":"14 (Pt 4)","author":"Pearson","year":"2000","journal-title":"Eye (Lond)"},{"key":"2025090109580751000_8.1.e001175.10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12886-021-01992-6","article-title":"Generalisability through local validation: overcoming barriers due to data disparity in healthcare","volume":"21","author":"Mitchell","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"2025090109580751000_8.1.e001175.11","unstructured":"Home - clinicaltrials.gov. Available: https:\/\/clinicaltrials.gov\/ct2\/home [Accessed 22 Jun 2022]."},{"key":"2025090109580751000_8.1.e001175.12","unstructured":"NOT-OD-15-089: racial and ethnic categories and definitions for NIH diversity programs and for other reporting purposes. Available: https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/not-od-15-089.html [Accessed 21 Jun 2022]."},{"key":"2025090109580751000_8.1.e001175.13","unstructured":"World bank country and lending groups \u2013 world bank data help desk. Available: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups [Accessed 23 Jun 2022]."},{"key":"2025090109580751000_8.1.e001175.14","first-page":"5469","article-title":"Reporting and enrollment of women and racial minorities in ophthalmic clinical trials","volume":"60","author":"Hamid","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025090109580751000_8.1.e001175.15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamaophthalmol.2020.3969","article-title":"Strategies to address racial and ethnic disparities in vision care research","volume":"138","author":"Liu","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"2025090109580751000_8.1.e001175.16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.25259\/IHOPEJO_15_2021","article-title":"The Lancet global health Commission on global eye health: vision beyond 2020","volume":"1","author":"Burton","year":"2022","journal-title":"IHOPEJO"},{"key":"2025090109580751000_8.1.e001175.17","doi-asserted-by":"crossref","unstructured":"Administration USD of H&. HSFAD ,. FDA unveils 5-part strategic action plan to \u201cProtect and advance america\u2019s health. PsycEXTRA Dataset 2003. doi:10.1037\/e310612004-001","DOI":"10.1037\/e310612004-001"},{"key":"2025090109580751000_8.1.e001175.18","doi-asserted-by":"crossref","unstructured":"Hayunga EG , Pinn VW . NIH policy on the inclusion of women and minorities as subjects in clinical research. Principles and Practice of Clinical Research 2002:145\u201360. doi:10.1016\/b978-012274065-7\/50013-7","DOI":"10.1016\/B978-012274065-7\/50013-7"},{"key":"2025090109580751000_8.1.e001175.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1101549"},{"key":"2025090109580751000_8.1.e001175.20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.8348","article-title":"Racial and ethnic disparities in primary open-angle glaucoma clinical trials: a systematic review and meta-analysis","volume":"4","author":"Allison","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"Suppl 5","key":"2025090109580751000_8.1.e001175.21","doi-asserted-by":"crossref","first-page":"S668","DOI":"10.2105\/AJPH.2015.302892","article-title":"Racial and ethnic disparities in services and the patient protection and Affordable care act","volume":"105 Suppl 5","author":"Abdus","year":"2015","journal-title":"Am J Public Health"},{"key":"2025090109580751000_8.1.e001175.22","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301706"},{"key":"2025090109580751000_8.1.e001175.23","article-title":"Interventions to increase attendance for diabetic retinopathy screening","volume":"1","author":"Lawrenson","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090109580751000_8.1.e001175.24","article-title":"Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries","volume":"11","author":"Ramke","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090109580751000_8.1.e001175.25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/OPTH.S2561","article-title":"Potential bias in ophthalmic pharmaceutical clinical trials","volume":"2","author":"Varner","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"2025090109580751000_8.1.e001175.26","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30488-5"},{"key":"2025090109580751000_8.1.e001175.27","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/ceo.13838","article-title":"Updating the model of eye care for Aboriginal populations in remote central Australia","volume":"48","author":"Mitchell","year":"2020","journal-title":"Clin Exp Ophthalmol"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2022-001175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:58:15Z","timestamp":1756745895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2022-001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2,23]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/bmjophth-2022-001175"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2022-001175","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}